Related references
Note: Only part of the references are listed.2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS) Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT)
Nazzareno Galie et al.
EUROPEAN HEART JOURNAL (2016)
Exaggerated Hypoxic Pulmonary Vasoconstriction Without Susceptibility to High Altitude Pulmonary Edema
Christoph Dehnert et al.
HIGH ALTITUDE MEDICINE & BIOLOGY (2015)
Sarpogrelate hydrochloride, a serotonin 5HT2A receptor antagonist, ameliorates the development of chronic hypoxic pulmonary hypertension in rats
Erquan Zhang et al.
JOURNAL OF ANESTHESIA (2015)
Cigarette Smoke-Induced Emphysema and Pulmonary Hypertension Can Be Prevented by Phosphodiesterase 4 and 5 Inhibition in Mice
Michael Seimetz et al.
PLOS ONE (2015)
Bosentan in Pulmonary Hypertension Associated with Fibrotic Idiopathic Interstitial Pneumonia
Tamera J. Corte et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2014)
Stimulation of Soluble Guanylate Cyclase Prevents Cigarette Smoke-induced Pulmonary Hypertension and Emphysema
Norbert Weissmann et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2014)
P2Y1 and P2Y12 receptors in hypoxia- and adenosine diphosphate-induced pulmonary vasoconstriction in vivo in the pig
David Kylhammar et al.
EUROPEAN JOURNAL OF APPLIED PHYSIOLOGY (2014)
Regulation of the skeletal muscle blood flow in humans
Stefan P. Mortensen et al.
EXPERIMENTAL PHYSIOLOGY (2014)
Tadalafil in patients with chronic obstructive pulmonary disease: a randomised, double-blind, parallel-group, placebo-controlled trial
Andrew R. Goudie et al.
LANCET RESPIRATORY MEDICINE (2014)
Sildenafil to improve respiratory rehabilitation outcomes in COPD: a controlled trial
Isabel Blanco et al.
EUROPEAN RESPIRATORY JOURNAL (2013)
Pulmonary hypertension and the right ventricle in hypoxia
Robert Naeije et al.
EXPERIMENTAL PHYSIOLOGY (2013)
Efficacy of tadalafil in chronic hypobaric hypoxiainduced pulmonary hypertension: possible mechanisms
Masrat Rashid et al.
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2013)
Pulmonary arterial lesions in explanted lungs after transplantation correlate with severity of pulmonary hypertension in chronic obstructive pulmonary disease
Jorn Carlsen et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2013)
Pulmonary Hypertension in Chronic Lung Diseases
Werner Seeger et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Pulmonary Hypertension as a Prognostic Indicator at the Initial Evaluation in Idiopathic Pulmonary Fibrosis
Motohiro Kimura et al.
RESPIRATION (2013)
Dual endothelin receptor blockade with tezosentan markedly attenuates hypoxia-induced pulmonary vasoconstriction in a porcine model
P. Hedelin et al.
ACTA PHYSIOLOGICA (2012)
sGC stimulation totally reverses hypoxia-induced pulmonary vasoconstriction alone and combined with dual endothelin-receptor blockade in a porcine model
J. Lundgren et al.
ACTA PHYSIOLOGICA (2012)
Cyclooxygenase-2 inhibition and thromboxane A2 receptor antagonism attenuate hypoxic pulmonary vasoconstriction in a porcine model
D. Kylhammar et al.
ACTA PHYSIOLOGICA (2012)
Mechanisms of pulmonary hypertension in chronic obstructive pulmonary disease: A pathophysiologic review
Jeremy P. Wrobel et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2012)
Prevalence, predictors, and survival in pulmonary hypertension related to end-stage chronic obstructive pulmonary disease
Kasper Hasseriis Andersen et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2012)
HYPOXIC PULMONARY VASOCONSTRICTION
J. T. Sylvester et al.
PHYSIOLOGICAL REVIEWS (2012)
Furegrelate, a Thromboxane Synthase Inhibitor, Blunts the Development of Pulmonary Arterial Hypertension in Neonatal Piglets
Dinesh K. Hirenallur-S et al.
Pulmonary Circulation (2012)
Bosentan Effects in Hypoxic Pulmonary Vasoconstriction: Preliminary Study in Subjects with or without High Altitude Pulmonary Edema-History
Isabelle Pham et al.
Pulmonary Circulation (2012)
Identification of Contractile P2Y1, P2Y6, and P2Y12 Receptors in Rat Intrapulmonary Artery Using Selective Ligands
Callum Mitchell et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2012)
Endothelium-mediated control of vascular tone: COX-1 and COX-2 products
Michel Feletou et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Effects of inhaled nitric oxide at rest and during exercise in idiopathic pulmonary fibrosis
Isabel Blanco et al.
JOURNAL OF APPLIED PHYSIOLOGY (2011)
Analysis of responses to the Rho-kinase inhibitor Y-27632 in the pulmonary and systemic vascular bed of the rat
David B. Casey et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2010)
Hemodynamic and Gas Exchange Effects of Sildenafil in Patients with Chronic Obstructive Pulmonary Disease and Pulmonary Hypertension
Isabel Blanco et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)
Endothelin receptors blockade blunts hypoxia-induced increase in PAP in humans
I. Pham et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2010)
BAY 41-2272 inhibits the development of chronic hypoxic pulmonary hypertension in rats
Lise Bech Thorsen et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2010)
Treprostinil inhibits the recruitment of bone marrow-derived circulating fibrocytes in chronic hypoxic pulmonary hypertension
V. S. Nikam et al.
EUROPEAN RESPIRATORY JOURNAL (2010)
Pulmonary artery pressure limits exercise capacity at high altitude
R. Naeije et al.
EUROPEAN RESPIRATORY JOURNAL (2010)
Regulation of the Pulmonary Circulation in the Fetus and Newborn
Yuansheng Gao et al.
PHYSIOLOGICAL REVIEWS (2010)
New Insights in the Pathogenesis of High-Altitude Pulmonary Edema
Urs Scherrer et al.
PROGRESS IN CARDIOVASCULAR DISEASES (2010)
Effects of hypercapnia with and without acidosis on hypoxic pulmonary vasoconstriction
Farzaneh Ketabchi et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2009)
Dexamethasone But Not Tadalafil Improves Exercise Capacity in Adults Prone to High-Altitude Pulmonary Edema
Manuel Fischler et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2009)
Bosentan Decreases Pulmonary Vascular Resistance and Improves Exercise Capacity in Acute Hypoxia
Vitalie Faoro et al.
CHEST (2009)
First acute haemodynamic study of soluble guanylate cyclase stimulator riociguat in pulmonary hypertension
F. Grimminger et al.
EUROPEAN RESPIRATORY JOURNAL (2009)
Ventilation-perfusion imbalance and chronic obstructive pulmonary disease staging severity
Roberto Rodriguez-Roisin et al.
JOURNAL OF APPLIED PHYSIOLOGY (2009)
Analysis of pulmonary vasodilator responses to the Rho-kinase inhibitor fasudil in the anesthetized rat
Adeleke M. Badejo et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2008)
Inhalation of the ETA receptor antagonist LU-135252 selectively attenuates hypoxic pulmonary vasoconstriction
Bodil Petersen et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2008)
Plasma pro-adrenomedullin but not plasma pro-endothelin predicts survival in exacerbations of COPD
Daiana Stolz et al.
CHEST (2008)
Absence of cyclooxygenase-2 exacerbates hypoxia-induced pulmonary hypertension and enhances contractility of vascular smooth muscle cells
Laura E. Fredenburgh et al.
CIRCULATION (2008)
Expression and function of soluble guanylate cyclase in pulmonary arterial hypertension
R. T. Schermuly et al.
EUROPEAN RESPIRATORY JOURNAL (2008)
A randomised, controlled trial of bosentan in severe COPD
D. Stolz et al.
EUROPEAN RESPIRATORY JOURNAL (2008)
Intravenous tezosentan and vardenafil attenuate acute hypoxic pulmonary hypertension
Ralf Geiger et al.
HIGH ALTITUDE MEDICINE & BIOLOGY (2008)
Sildenafil acutely reverses the hypoxic pulmonary vasoconstriction response of the newborn pig
Roger Tessler et al.
PEDIATRIC RESEARCH (2008)
Luminal ATP-induced contraction of rabbit pulmonary arteries and role of purinoceptors in the regulation of pulmonary arterial pressure
Eun Bok Baek et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2008)
Thromboxane A(2): Physiology/pathophysiology, cellular signal transduction and pharmacology
Norimichi Nakahata
PHARMACOLOGY & THERAPEUTICS (2008)
Pharmacological characterization of 3-azabicyclo[3,2,1]octane-1-yl-L-leucyl-D-tryptophanyl-D-4-Cl-phenylalanine: A novel ETA receptor-selective antagonist
Xin Li et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2008)
The role of angiotensin II receptor-1 blockade in the hypoxic pulmonary vasoconstriction response in newborn piglets
Jose Simon Camelo et al.
NEONATOLOGY (2008)
Hypoxia-induced pulmonary hypertension: Different impact of iloprost, sildenafil, and nitric oxide
Norbert Weissmann et al.
RESPIRATORY MEDICINE (2007)
Effects of sildenafil on exercise capacity in hypoxic normal subjects
Vitalie Faoro et al.
HIGH ALTITUDE MEDICINE & BIOLOGY (2007)
Significance of pulmonary arterial pressure and diffusion capacity of the lung as prognosticator in patients with idiopathic pulmonary fibrosis
Kunio Hamada et al.
CHEST (2007)
Cardioprotective prostacyclin signaling in vascular smooth muscle
Kristina M. Fetalvero et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2007)
Both tadalafil and dexamethasone may reduce the incidence of high-altitude pulmonary edema -: A randomized trial
Marco Maggiorini et al.
ANNALS OF INTERNAL MEDICINE (2006)
Hypoxia-induced pulmonary vascular remodeling - Cellular and molecular mechanisms
Kurt R. Stenmark et al.
CIRCULATION RESEARCH (2006)
Role of endothelin-1 in exposure to high altitude - Acute mountain sickness and endothelin-1 (ACME-1) study
Pietro Amedeo Modesti et al.
CIRCULATION (2006)
Cytochrome P450 epoxygenase gene function in hypoxic pulmonary vasoconstriction and pulmonary vascular remodeling
P Pokreisz et al.
HYPERTENSION (2006)
Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis
CJ Lettieri et al.
CHEST (2006)
Activation of soluble guanylate cyclase reverses experimental pulmonary hypertension and vascular remodeling
R Dumitrascu et al.
CIRCULATION (2006)
BAY 41-2272, a direct activator of soluble guanylate cyclase, reduces right ventricular hypertrophy and prevents pulmonary vascular remodeling during chronic hypoxia in neonatal rats
Philippe Deruelle et al.
BIOLOGY OF THE NEONATE (2006)
The expression of prostacyclin synthase is decreased in the small pulmonary arteries from patients with ernphysema
JD Lee et al.
CHEST (2005)
Multiple P2Y receptors couple to calcium-dependent, chloride channels in smooth muscle cells of the rat pulmonary artery
K Chootip et al.
RESPIRATORY RESEARCH (2005)
Thromboxane inhibition reduces an early stage of chronic hypoxia-induced pulmonary hypertension in piglets
CD Fike et al.
JOURNAL OF APPLIED PHYSIOLOGY (2005)
Sildenafil and an early stage of chronic hypoxia-induced pulmonary hypertension in newborn piglets
KM Binns-Loveman et al.
PEDIATRIC PULMONOLOGY (2005)
A novel and selective endothelin ETA receptor antagonist YM598 prevents the development of chronic hypoxia-induced pulmonary hypertension in rats
H Yuyama et al.
VASCULAR PHARMACOLOGY (2005)
Endothelin-A receptor blockade prevents and partially reverses neonatal hypoxic pulmonary vascular remodeling
N Ambalavanan et al.
PEDIATRIC RESEARCH (2005)
Lack of synergistic effect of molsidomine and sildenafil on development of pulmonary hypertension in chronic hypoxic rats
CU Andersen et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2005)
Sildenafil inhibits altitude-induced hypoxemia and pulmonary hypertension
JP Richalet et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2005)
NOS3 deficiency augments hypoxic pulmonary vasoconstriction and enhances systemic oxygenation during one-lung ventilation in mice
R Liu et al.
JOURNAL OF APPLIED PHYSIOLOGY (2005)
Role of veins in regulation of pulmonary circulation
YS Gao et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2005)
cAMP phosphodiesterase inhibitors potentiate effects of prostacyclin analogs in hypoxic pulmonary vascular remodeling
PG Phillips et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2005)
Right ventricular adaptation to pulmonary hypertension: an interspecies comparison
P Wauthy et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2004)
Basic features of hypoxic pulmonary vasoconstriction in mice
N Weissmann et al.
RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY (2004)
Attenuation of acute hypoxic pulmonary vasoconstriction and hypoxic pulmonary hypertension in mice by inhibition of Rho-kinase
KA Fagan et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2004)
Sildenafil increased exercise capacity during hypoxia at low altitudes and at Mount Everest Base Camp - A randomized, double-blind, placebo-controlled crossover trial
HA Ghofrani et al.
ANNALS OF INTERNAL MEDICINE (2004)
Endogenous angiotensin II in the regulation of hypoxic pulmonary vasoconstriction in anaesthetized dogs
I Hubloue et al.
CRITICAL CARE (2004)
P2Y purine receptor responses and expression in the pulmonary circulation of juvenile rabbits
GG Konduri et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2004)
ATP-induced mitogenesis is mediated by cyclic AMP response element-binding protein-enhanced TRPC4 expression and activity in human pulmonary artery smooth muscle cells
S Zhang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2004)
Intravascular thrombosis after hypoxia-induced pulmonary hypertension - Regulation by cyclooxygenase-2
GP Pidgeon et al.
CIRCULATION (2004)
Sildenafil prevents change in RhoA expression induced by chronic hypoxia in rat pulmonary artery
V Sauzeau et al.
CIRCULATION RESEARCH (2003)
Serotonin transporter inhibitors protect against hypoxic pulmonary hypertension
E Marcos et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2003)
Phosphodiesterase type 5 as a target for the treatment of hypoxia-induced pulmonary hypertension
A Sebkhi et al.
CIRCULATION (2003)
Endogenous NO does not regulate baseline pulmonary pressure, but reduces acute pulmonary hypertension in dogs
M Sander et al.
ACTA PHYSIOLOGICA SCANDINAVICA (2003)
COX and the control of the pulmonary circulation
RS Sprague et al.
THROMBOSIS RESEARCH (2003)
Vasoreactions to acute hypoxia, whole lungs and isolated vessels compared: modulation by NO
CJ Emery et al.
RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY (2003)
Determinants of maximal oxygen uptake in severe acute hypoxia
JAL Calbet et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2003)
Effects of ET-A receptor blockade on eNOS gene expression in chronic hypoxic rat lungs
FC Blumberg et al.
JOURNAL OF APPLIED PHYSIOLOGY (2003)
Endogenous endothelins and nitric oxide in hypoxic pulmonary vasoconstriction
I Hubloue et al.
EUROPEAN RESPIRATORY JOURNAL (2003)
Pharmacological evidence for a novel cysteinyl-leukotriene receptor subtype in human pulmonary artery smooth muscle
L Walch et al.
BRITISH JOURNAL OF PHARMACOLOGY (2002)
Regional variation in P2 receptor expression in the rat pulmonary arterial circulation
K Chootip et al.
BRITISH JOURNAL OF PHARMACOLOGY (2002)
Function of the serotonin 5-hydroxytryptamine 2B receptor in pulmonary hypertension
JM Launay et al.
NATURE MEDICINE (2002)
Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial
HA Ghofrani et al.
LANCET (2002)
Endothelium-derived mediators and hypoxic pulmonary vasoconstriction
PI Aaronson et al.
RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY (2002)
Contribution of endothelin to pulmonary vascular tone under normoxic and hypoxic conditions
W Johnson et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2002)
The endothelin A receptor antagonists PD 156707 (CI-1020) and PD 180988 (CI-1034) reverse the hypoxic pulmonary vasoconstriction in the perinatal lamb
Y Coe et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Exaggerated hypoxic pulmonary hypertension in endothelin B receptor-deficient rats
DD Ivy et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2002)
Hypoxia-induced pulmonary endothelin-1 expression is unaltered by nitric oxide
S Earley et al.
JOURNAL OF APPLIED PHYSIOLOGY (2002)
Hypoxia-induced secretion of serotonin from intact pulmonary neuroepithelial bodies in neonatal rabbit
XW Fu et al.
JOURNAL OF PHYSIOLOGY-LONDON (2002)
Contribution of the 5-HT1B receptor to hypoxia-induced pulmonary hypertension -: Converging evidence using 5-HT1B-receptor knockout mice and the 5-HT1B/1D-receptor antagonist GR127935
A Keegan et al.
CIRCULATION RESEARCH (2001)
TBC3711, an ETA receptor antagonist, reduces neonatal hypoxia-induced pulmonary hypertension in piglets
T Perreault et al.
PEDIATRIC RESEARCH (2001)
Sildenafil inhibits hypoxia-induced pulmonary hypertension
L Zhao et al.
CIRCULATION (2001)
Hypoxia decreases exhaled nitric oxide in mountaineers susceptible to high-altitude pulmonary edema
T Busch et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2001)
Exhaled nitric oxide in high-altitude pulmonary edema - Role in the regulation of pulmonary vascular tone and evidence for a role against inflammation
H Duplain et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2000)
The red blood cell as an oxygen sensor: what is the evidence?
ML Ellsworth
ACTA PHYSIOLOGICA SCANDINAVICA (2000)
Attenuation of pulmonary vascular hypertension and cardiac hypertrophy with sitaxsentan sodium, an orally active ETA receptor antagonist
RG Tilton et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2000)
Share Paper
